Form 4: Progyny CFO Sells Shares Under 10b5-1 Plan

Progyny's Chief Financial Officer, Mark S. Livingston, sold 459 shares of common stock for $25.5 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Mark S. Livingston, the Chief Financial Officer of Progyny, Inc. (PGNY), reported a transaction involving the company's common stock.
• On December 11, 2025, Mr. Livingston disposed of 459 shares of common stock.
• The shares were sold at a price of $25.5 per share.
• This sale was conducted pursuant to a Rule 10b5-1 trading plan, which was established on August 15, 2025.
• Following this transaction, Mr. Livingston beneficially owns 46,983 shares of Progyny, Inc. common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are generally considered non-discretionary and do not typically signal a change in management's sentiment or outlook on the company's prospects, thus indicating a neutral sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction filing and does not provide specific insights into broader industry trends or competitive landscape. Such sales under 10b5-1 plans are common among executives for personal financial planning.

Stakeholder Impact

• Shareholders: Minimal direct impact as the sale is a pre-scheduled, non-discretionary transaction under a 10b5-1 plan, which typically does not reflect new information about the company's performance or prospects.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider trading report.

Key Dates

Keywords

Progyny, PGNY, Insider Trading, Form 4, Stock Sale, CFO, 10b5-1 Plan, Beneficial Ownership